Implementation and evaluation of a harm-reduction model for clinical care of substance using pregnant women

Harm Reduction Journal

Volumn 9, Issue , 2012, Pages

  Wright, Tricia E ^a   Schuetter, Renee ^b   Fombonne, Eric ^c   Stephenson, Jessica ^b   Haning III, William F ^a  

^a UNIVERSITY OF HAWAII   (United States)

^b Perinatal Addiction Treatment of Hawaii   (United States)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Birth outcomes; Harm reduction; Methamphetamines; Pregnancy; Tobacco

Indexed keywords

ALCOHOL; BUPRENORPHINE; CANNABIS; COCAINE; METHADONE; METHAMPHETAMINE; OPIATE; OXYCODONE;

ARTICLE; CHILD PARENT RELATION; CONTRACEPTION; DOMESTIC VIOLENCE; FAMILY PLANNING; FEMALE; FETUS DEATH; FINGER MALFORMATION; FIRST TRIMESTER PREGNANCY; HARM REDUCTION; HARM REDUCTION MODEL; HOMELESSNESS; HUMAN; HYDROCELE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN INTENSIVE CARE; NONBIOLOGICAL MODEL; OPIATE ADDICTION; PARITY; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURITY; PRENATAL CARE; PUERPERAL DEPRESSION; SPONTANEOUS ABORTION; SUBSTANCE ABUSE;

EID: 84855895623     PISSN: None     EISSN: 14777517     Source Type: Journal    
DOI: 10.1186/1477-7517-9-5     Document Type: Article

References (57)

1. NIH National Institute of Justice: Preliminary Data on Drug Use and Related Matters Among Adult Arrestees and Juvenile Detainees. 2003, NIH.
2. Anglin MD, Burke C, Perrochet B, Stamper E, Dawud-Noursi S. History of the methamphetamine problem. J Psychoactive Drugs 2000, 32:137-141. 10.1080/02791072.2000.10400221, 10908000.
3. NIH Epidemiologic Trends in Drug Abuse Advance Report. 2002, NIH.
4. NIH Research Reports: Methamphetamine Abuse and Addiction. 2002, NIH.
5. Terplan M, Smith EJ, Kozloski MJ, Pollack HA. Methamphetamine use among pregnant women. Obstet Gynecol 2009, 113:1285-1291.
6. SAMHSA Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of National Findings (Office of Applied Studies, NSDUH Series H-38A, HHS Publication No. SMA 10-4856 Findings). Rockville, MD. 2010, SAMHSA.
7. SAMHSA Office of Applied Studies National Estimates of Drug-Related Emergency Department Visits. 2007, SAMHSA Office of Applied Studies.
8. Zilberman ML, Tavares H, Blume SB, el-Guebaly N. Substance use disorders: sex differences and psychiatric comorbidities. Can J Psychiatry 2003, 48:5-13.
9. Gil-Rivas V, Fiorentine R, Anglin MD. Sexual abuse, physical abuse, and posttraumatic stress disorder among women participating in outpatient drug abuse treatment. J Psychoactive Drugs 1996, 28:95-102. 10.1080/02791072.1996.10471718, 8714338.
10. Najavits LM, Weiss RD, Shaw SR. The link between substance abuse and posttraumatic stress disorder in women. A research review. Am J Addict 1997, 6:273-283.
11. Simpson TL, Miller WR. Concomitance between childhood sexual and physical abuse and substance use problems. A review. Clin Psychol Rev 2002, 22:27-77. 10.1016/S0272-7358(00)00088-X, 11793578.
12. Smith RC, Blumenthal H, Badour C, Feldner MT. An investigation of relations between crystal methamphetamine use and posttraumatic stress disorder. Addict Behav 2010, 35:625-627. 10.1016/j.addbeh.2010.01.010, 20153121.
13. Semple SJ, Zians J, Strathdee SA, Patterson TL. Psychosocial and behavioral correlates of depressed mood among female methamphetamine users. J Psychoactive Drugs 2007, Suppl 4:353-366.
14. Cohen JB, Greenberg R, Uri J, Halpin M, Zweben JE. Women with methamphetamine dependence: research on etiology and treatment. J Psychoactive Drugs 2007, Suppl 4:347-351.
15. Brecht ML, O'Brien A, von Mayrhauser C, Anglin MD. Methamphetamine use behaviors and gender differences. Addict Behav 2004, 29:89-106. 10.1016/S0306-4603(03)00082-0, 14667423.
16. Piran N, Robinson S. The association between disordered eating and substance use and abuse in women: a community-based investigation. Women Health 2006, 44:1-20. 10.1300/J013v44n01_01, 17456461.
17. Corstorphine E, Waller G, Lawson R, Ganis C. Trauma and multi-impulsivity in the eating disorders. Eat Behav 2007, 8:23-30. 10.1016/j.eatbeh.2004.08.009, 17174848.
18. Bates B. Body image varies greatly among Asian groups. Clinical Psychiatry News 2004,
19. Lorvick J, Martinez A, Gee L, Kral AH. Sexual and injection risk among women who inject methamphetamine in San Francisco. J Urban Health 2006, 83:497-505. 10.1007/s11524-006-9039-4, 2527191, 16739050.
20. Plessinger MA. Prenatal exposure to amphetamines. Risks and adverse outcomes in pregnancy. Obstet Gynecol Clin North Am 1998, 25:119-138. 10.1016/S0889-8545(05)70361-2, 9547763.
21. Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. Drugs in Pregancy and Lactation 2007, Philadelphia: Lippincot Williams & Wilkins, Siegafuse S and Shaw R.
22. Schempf A. Illicit drug use and neonatal outcomes: a critical review. Obstet Gynecol Surv 2007, 62:749-757. 10.1097/01.ogx.0000286562.31774.76, 17925048.
23. Smith LM, LaGasse LL, Derauf C, Grant P, Shah R, Arria A, Huestis M, Haning W, Strauss A, Della Grotta S, et al. The infant development, environment, and lifestyle study: effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth. Pediatrics 2006, 118:1149-1156. 10.1542/peds.2005-2564, 16951010.
24. Lester BM, Lagasse LL. Children of addicted women. J Addict Dis 2010, 29:259-276. 10.1080/10550881003684921, 20407981.
25. Eriksson M, Larsson G, Zetterstrom R. Amphetamine addiction and pregnancy. II. Pregnancy, delivery and the neonatal period. Socio-medical aspects. Acta Obstet Gynecol Scand 1981, 60:253-259. 10.3109/00016348109158127, 7270093.
26. Oro AS, Dixon SD. Perinatal cocaine and methamphetamine exposure: maternal and neonatal correlates. J Pediatr 1987, 111:571-578. 10.1016/S0022-3476(87)80125-7, 3655989.
27. Little BB, Snell LM, Gilstrap LC. Methamphetamine abuse during pregnancy: outcome and fetal effects. Obstet Gynecol 1988, 72:541-544.
28. Albertson TE, Derlet RW, Van Hoozen BE. Methamphetamine and the expanding complications of amphetamines. West J Med 1999, 170:214-219. 1305551, 10344175.
29. Cox S, Posner SF, Kourtis AP, Jamieson DJ. Hospitalizations with amphetamine abuse among pregnant women. Obstet Gynecol 2008, 111:341-347. 10.1097/01.AOG.000300377.82722.ad, 18238971.
30. Wright TE, Tam E. Disparate rates of persistent smoking and drug use during pregnancy of women of Hawaiian ancestry. Ethn Dis 2010, 20:S1-215-218.
31. Smith L, LaGasse L, Derauf C, Lester B. Intrauterine Growth of Infants Exposed to Prenatal Methamphetamine: Preliminary Results from the Infant Development, Environment, and Lifestyle Study (IDEAL). Pediatric Research 2004, 55:72A.
32. Smith L, Yonekura ML, Wallace T, Berman N, Kuo J, Berkowitz C. Effects of prenatal methamphetamine exposure on fetal growth and drug withdrawal symptoms in infants born at term. J Dev Behav Pediatr 2003, 24:17-23. 10.1097/00004703-200302000-00006, 12584481.
33. Chang L, Alicata D, Ernst T, Volkow N. Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction 2007, 102(Suppl 1):16-32.
34. Chang L, Cloak C, Jiang CS, Farnham S, Tokeshi B, Buchthal S, Hedemark B, Smith LM, Ernst T. Altered neurometabolites and motor integration in children exposed to methamphetamine in utero. Neuroimage 2009, 48:391-397. 10.1016/j.neuroimage.2009.06.062, 3142567, 19576287.
35. Chang L, Smith LM, LoPresti C, Yonekura ML, Kuo J, Walot I, Ernst T. Smaller subcortical volumes and cognitive deficits in children with prenatal methamphetamine exposure. Psychiatry Res 2004, 132:95-106. 10.1016/j.pscychresns.2004.06.004, 15598544.
36. Cloak CC, Ernst T, Fujii L, Hedemark B, Chang L. Lower diffusion in white matter of children with prenatal methamphetamine exposure. Neurology 2009, 72:2068-2075. 10.1212/01.wnl.0000346516.49126.20, 2697962, 19369643.
37. Smith LM, Chang L, Yonekura ML, Grob C, Osborn D, Ernst T. Brain proton magnetic resonance spectroscopy in children exposed to methamphetamine in utero. Neurology 2001, 57:255-260.
38. McGourty R, Chasnoff I. Power Beyond Measure 2003, Chicago, Illinois: NTI Publishing.
39. Ritter A, Cameron J. A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs. Drug Alcohol Rev 2006, 25:611-624. 10.1080/09595230600944529, 17132577.
40. SAMHSA What You Need To Know. The Effect of Alcohol on a Fetus. DHHS Publication No (SMA) 07-4275 2007, SAMHSA.
41. El-Mohandes A, Herman AA, Nabil El-Khorazaty M, Katta PS, White D, Grylack L. Prenatal care reduces the impact of illicit drug use on perinatal outcomes. J Perinatol 2003, Jul-Aug:354-360.
42. Poole N. Evaluation report of the Sheway Project for high-risk pregnant and parenting women. 2000, Vancouver, British Columbia: British Columbia Centre of Excellence for Women's Health.
43. Macrory F, Boyd SC. Developing primary and secondary services for drug and alcohol dependent mothers. Semin Fetal Neonatal Med 2007, 12:119-126. 10.1016/j.siny.2007.01.005, 17344108.
44. Miller WR, Resnick S. Motivational interviewing: preparing people for change 2002, New York, NY: The Guilford Press, 2.
45. Prochaska JO. Systems of psychotherapy: A transtheoretical analysis 1979, Homewood. Illinois: Dorsey Press.
46. Najavits LM. Seeking Safety 2002, New York, NY: The Guilford Press.
47. Covington SS. A Woman's way through the twelve steps 1994, Center City, Minnesota: Hazelden.
48. Carroll KM, Onken LS. Behavioral therapies for drug abuse. Am J Psychiatry 2005, 162:1452-1460. 10.1176/appi.ajp.162.8.1452, 16055766.
49. Petry NM, Simcic F. Recent advances in the dissemination of contingency management techniques: clinical and research perspectives. J Subst Abuse Treat 2002, 23:81-86. 10.1016/S0740-5472(02)00251-9, 12220605.
50. Perinatal Statistics. , http://www.marchofdimes.com/peristats/
51. McCann KJ, Twomey JE, Caldwell D, Soave R, Fontaine LA, Lester BM. Services used by perinatal substance-users with child welfare involvement: a descriptive study. Harm Reduct J 2010, 7:19. 10.1186/1477-7517-7-19, 2944302, 20807432.
52. Burkett G, Gomez-Marin O, Yasin SY, Martinez M. Prenatal care in cocaine-exposed pregnancies. Obstet Gynecol 1998, Aug:193-200.
53. Schaper AM, Rooney BL, Kay NR, Silva PD. Use of the Edinburgh Postnatal Depression Scale to identify postpartum depression in a clinical setting. J Reprod Med 1994, 39:620-624.
54. Mayberry LJ, Horowitz JA, Declercq E. Depression symptom prevalence and demographic risk factors among U.S. women during the first 2 years postpartum. J Obstet Gynecol Neonatal Nurs 2007, 36:542-549. 10.1111/j.1552-6909.2007.00191.x, 17973697.
55. Selected Chronic and Other Health Conditions By Age and Gender. , http://hawaii.gov/health/statistics/hhs/hhs_08/hhs08t46.pdf
56. Field T, Diego M, Hernandez-Reif M. Prenatal depression effects on the fetus and newborn: a review. Infant Behav Dev 2006, 29:445-455. 10.1016/j.infbeh.2006.03.003, 17138297.
57. Hawaii State Department of Health Medicaid/QUEST Birth Outcomes Fact Sheet. Hawaii State Department of Health., http://hawaii.gov/health/family-child-health/mchb/prams-doc/medicaid